3M Co said on Tuesday that Bryan Hanson would be the chief executive officer of the healthcare company it plans to spin off.
3M last year disclosed plans to spin off its healthcare business into a listed company, in which the U.S. industrial giant would retain a 19.9% stake. The company expects to complete the spinoff by the end of 2023.
The health care unit, which focuses on wound care, oral care and healthcare technology, accounted for about 25% of 3M’s $34.23 billion in sales last year.
Hanson joins 3M from Indiana-based medical equipment maker Zimmer Biomet, where he was president and CEO since 2017, and chairman since 2021.
Hanson would join 3M on Sept. 1 as CEO of Health Care Business Group, the company said.
3M also said Carrie Cox, who has previously served as chairman and CEO of human tissue developer Humacyte Inc, would take on the role of the chairman of the board of directors of the health care unit.
Monish Patolawala would take on the expanded role of president of 3M Co from Sept. 1. He is currently the executive vice president and chief financial and transformation officer at the company.
Source : Reuters
This essay analyses the causes of, and remedies for, external imbalances, and what countries should…
Rising rates are testing Japan’s fiscal framework, with debt dynamics hinging on growth and pointing…
With a return to the pre-Iran conflict energy status quo unlikely, a Hormuz toll may…
US firms’ rise in EU asset management may weaken sustainable finance, making tougher stewardship, ESMA…
When global uncertainty increases, emerging markets are typically the most exposed. Historically, tighter US monetary…
Global imbalances are back, and the lesson from history is that they often end in…